2. 1-24 of 58 1 2 3 »

    1. Dr. Michael Leitner will Give Webcast on Non-Medical Applications of OCT April 11th, 2013

      Explore BioOptics World NDE/NDT
      Dr. Michael Leitner will Give Webcast on Non-Medical Applications of OCT April 11th, 2013

      In this webcast, Dr. Michael Leitner, head of the optical coherence tomography group at RECENDT - Research Center for Non Destructive Testing GmbH (Linz, Austria) discusses the application of OCT as a tool for microstructure analysis, device characterization, and quality control in materials science and industry.

      Read Full Article
      Mentions: Michael Leitner RECENDT

    2. Swanson inspires with OCT review at Laser Marketplace Seminar

      Explore BioOptics World
      Swanson inspires with OCT review at Laser Marketplace Seminar

      In his presentation on optical coherence tomography (OCT) during the 2013 Laser Marketplace Seminar (at Photonics West), Eric Swanson , serial entrepreneur and publisher of OCTnews , provided a comprehensive tour of OCT applications and implementations -- the vast majority of them biomedical. Swanson is a fantastic spokesperson for OCT thanks not only to his pioneering role in its development, but also to his tracking and analysis of its progress. For instance, he outlined the ROI of government support for OCT by discussing the technology's impact on the economy in terms of dollars and jobs, and on patient care (one OCT scan ...

      Read Full Article
      Mentions: Barbara G. Goode Eric A. Swanson NinePoint Medical

    3. Novel ophthalmic imaging with adaptive optics, confocal imaging, and OCT

      Explore BioOptics World Ophthalmology
      Novel ophthalmic imaging with adaptive optics, confocal imaging, and OCT

      A bio-optics triple-threat—a combination of adaptive optics, optical coherence tomography, and confocal microscopy—allows imaging of the human eye with unprecedented detail. It promises to enable more accurate clinical analysis for detection of diseases such as macular degeneration and glaucoma, with the ultimate goal of reducing blindness. The human eye is complex and powerful, but extremely vulnerable—far more susceptible than any other organ to ailments via blunt force, bacterial infection, and exposure. While researchers have developed numerous innovations for the detection and treatment of these conditions, there is still plenty of opportunity to enhance ophthalmic diagnostic and treatment ...

      Read Full Article
      Mentions: University of Rochester

    4. Grant for students supports OCT-related travel expenses

      Explore BioOptics World
      Grant for students supports OCT-related travel expenses
      OCT News, in collaboration with Sensors Unlimited – Goodrich ISR Systems (Princeton, NJ), has launched its annual Student Travel Grant Awards program, which assists students with travel expenses for optical coherence tomography (OCT)-related conferences or meetings, according to publisher Eric Swanson. Such conferences and meetings include SPIE BiOS/Photonics West in San Francisco, CA (this year's will be held January 21–26). Zhao Wang is one of four student applicants who qualify for the $1,000 travel award this year, based on judges’ scores for technical merit, clarity, and novelty in the field of OCT. Working with Dr. Andrew ...
      Read Full Article
      Mentions: Andrew M. Rollins Case Western Reserve University Goodrich Corporation

    5. OPTICAL COHERENCE TOMOGRAPHY/BIOIMAGING: One decade and $500M: The impact of federal funding on OCT - Part 2

      Explore BioOptics World
      OPTICAL COHERENCE TOMOGRAPHY/BIOIMAGING: One decade and $500M: The impact of federal funding on OCT - Part 2
      EDITOR'S NOTE: This article is the follow-up article to "One decade and $500M: The impact of federal funding on OCT—Part 1," which appears in the September/October 2011 issue of BioOptics World. Over the past decade, governments around the world have invested hundreds of millions of dollars in research and development involving optical coherence tomography (OCT). Part Two of this two-part article explores the return on that investment in terms of product and economic growth in the for-profit sector. By Eric A. Swanson As discussed in Part 1 of this article, determining the impact of research dollars for ...
      Read Full Article
      Mentions: University of Toronto Massachusetts Institute of Technology Tomophase Corporation

    6. Optical Coherence Tomography/Bioimaging: One decade and $500M: The impact of federal funding on OCT—Part 1

      Explore BioOptics World Funding
      Optical Coherence Tomography/Bioimaging: One decade and $500M: The impact of federal funding on OCT—Part 1
      Over the past decade, governments around the world have invested hundreds of millions of dollars in research and development involving optical coherence tomography (OCT). Part One of this two-part article explores where the money has come from, and where it has gone, and begins to uncover the return on that investment—which will be further explored in Part Two.
      Read Full Article
      Mentions: National Cancer Institute Massachusetts Institute of Technology National Institutes of Health

    7. BioOptics World Editors Column: Vitality all around

      Explore BioOptics World
      BioOptics World Editors Column: Vitality all around
      We’re pleased this issue to publish the first of a two-part article by Eric Swanson, a pioneer in optical coherence tomography (OCT), that discusses government investment in OCT as well as the return on that investment—in terms of diagnostics, patient outcomes. and research in multiple disciplines; plus job creation, revenue generation and other economic measures (see p. 30). This year OCT is celebrating its 20th anniversary, and since Swanson penned his article the technology has seen some interesting developments, including demonstration for the first time of the ability to reliably determine risk of pancreatic cancer, and European CE ...
      Read Full Article
      Mentions: Barbara G. Goode Eric A. Swanson

    8. Optical coherence tomography market grows into new phase

      Explore BioOptics World Other Business News
      JANUARY 5, 2010--"The market for OCT systems is entering a new phase as it moves beyond ophthalmology and is applied to new medical specialties," reports a new market research study by Strategies Unlimited (Mountain View, CA). Titled OCT 2010: Technology, Applications, and Markets, the report says that despite the dismal 2009 economy, sales of optical coherence tomography (OCT) systems grew to $315 million, and a compound annual growth rate of 20% is expected through 2014. The report is an update to the first study ever to quantify the OCT market. OCT systems use advanced optical techniques to construct micron-scale ...
      Read Full Article
      Mentions: Carl Zeiss Meditec Gregory Smolka Barbara G. Goode

    9. Bio-optics: Everywhere at once

      Explore BioOptics World
      Bio-optics watchers must be in multiple places simultaneously each autumn in order to experience first hand all the exciting work being reported at so many events. Besides BioOpto Japan and the World Molecular Imaging Congress (see reports starting on page 9) this fall’s schedule included the NIH/SPIE Inter-Institute Workshop on Optical Diagnostic and Biophotonic Methods from Bench to Bedside (October 1–2, Bethesda, MD) which focused on work to transition optical methods from the lab to clinical settings. Doug Malchow of Goodrich-Sensors Unlimited attended with a specific interest in optical coherence tomography (OCT), and said, “It was truly ...
      Read Full Article
      Mentions: Brett E. Bouma National Institutes of Health Massachusetts General Hospital

    10. Japanese research focus of BioOpto Japan

      Explore BioOptics World
      Japanese research focus of BioOpto Japan
      The inaugural BioOpto Japan (September 16–17, Yokohama) was held in conjunction with LED Japan Conference & Expo/Strategies in Light and OITDA 2009; together the events drew 7132 people. The three shared a seamless exhibits layout, and the BioOpto conference (see Fig. 1), which featured biomedical optics researchers from all over Japan, was set up right in the exhibit hall. The Japanese-language conference covered topics such as photodynamic therapy (PDT; Prof. Tsunenori Arai of Keio University), medical application of hollow optical fiber (Prof. Yuji Matsuura of Tohoku University), orange fiber lasers (Kasunobu Kojima of Nidek Co. Ltd), optical coherence tomography (OCT; Prof. Masamitsu Haruna of Osaka University ...
      Read Full Article
      Mentions: Thorlabs Nidek NTT

    11. IMAGING FOR OPHTHALMOLOGY: OCT explorations pervade ARVO/ISIE annual meeting

      Explore BioOptics World Ophthalmology
      At the annual meeting of the Association for Research in Vision and Ophthalmology/International Society for Imaging in the Eye (ARVO/ISIE; www.arvo.org; see www.bioopticsworld.com/articles/327003), 20 of the 24 presentations mentioned optical coherence tomography (OCT) in their titles. So did three posters–and nearly all of the other presentations referred to OCT. The event, held May 1 and 2 in Ft. Lauderdale, FL, attracted more than 140 of the world’s leading experts in ophthalmic imaging. The meeting’s goal is to present clinical and basic science advances in glaucoma, retina, cornea, anterior segment ...
      Read Full Article
      Mentions: Massachusetts Institute of Technology James G. Fujimoto

    12. Multibeam OCT scanner for skin imaging by Michelson Diagnostics

      Explore BioOptics World Probes
      The VivoSight Multi-Beam OCT (optical coherence tomography) scanner uses the high resolution capability of Michelson Diagnostics Ltd.'s (MDL) proprietary technology to image skin and other surface tissue with a hand-held probe. The compact, ergonomically designed probe promises an isotropic resolution of better than 10 microns to a depth of up to 2 mm. Scan rates vary from 6.5 fps to 35 fps depending on scan width, which, in turn, can be varied up to 5 mm.
      Read Full Article
      Mentions: Michelson Diagnostics Michelson Diagnostics Vivosight Barbara G. Goode

    13. Ultra broadband coherent light source for optical coherence tomography applications from Femtolasers

      Explore BioOptics World Other Business News
      Ultra broadband coherent light source for optical coherence tomography applications from Femtolasers
      Integral OCT is the third generation of Femtolasers' (Vienna, Austria) compact ultra broadband coherent light source for applications including ultra high-resolution optical coherence tomography (OCT), imaging of individual cells and sub-cellular structures, ultra high-speed 3D OCT, spectroscopic OCT, polarization-sensitive OCT, and spectrally encoded endoscopy. The device supports video rate 2D and 3D volume scans at ultra-high resolution.
      Read Full Article
      Mentions: Femtolasers Barbara G. Goode

    14. Fujimoto outlines OCT progress, opportunity during Hounsfield memorial prize ceremony

      Explore BioOptics World
      MIT professor and optical coherence tomography (OCT) pioneer James Fujimoto became the fifth annual Hounsfield memorial lecturer at the UK's Imperial College London Imaging Sciences Centre earlier this month. The annual event, designed to recognize the contribution of Sir Godfrey Hounsfield to medical imaging, is meant to showcase a world-leading researcher and review developments in imaging science. As part of the event, Fujimoto was presented with the 2009 Hounsfield medal.
      Read Full Article
      Mentions: James G. Fujimoto Michelson Diagnostics Carl Zeiss Meditec

    15. Quantum OCT images biological sample

      Explore BioOptics World
      For the first time, quantum optical coherence tomography (QOCT)1 has been proved viable for imaging biological samples. M. Boshra Nasr, a postdoctoral researcher in Boston University’s Quantum Imaging Laboratory led the work that has produced the first such experimental QOCT images. The approach is appealing because, unlike classical OCT, QOCT is inherently immune to group-velocity dispersion (GVD), which degrades the axial resolution. This immunity is a result of the frequency entanglement inhe
      Read Full Article
      Mentions: Boston University Barbara G. Goode

    16. Study shows benefit of confocal laser endomicroscopy for urology

      Explore BioOptics World Microscopy , Oncology , Urology
      APRIL 27, 2009--According to new data presented today at the American Urological Association's (AUA) Annual meeting, real-time, in vivo confocal endomicroscopy may help urologists to differentiate low and high-grade bladder tumors from normal bladder tissue. Mauna Kea Technologies' (Paris, France) Cellvizio probe-based confocal laser endomicroscopy (pCLE) system, which provides live images of internal human tissues at the cellular level, is the subject of the work.
      Read Full Article
      Mentions: Stanford University Mauna Kea Technologies Barbara G. Goode

    17. Cardiac imaging and OCT's legal mess

      Explore BioOptics World Cardiology , Other Business News
      "Word is getting out” about imaging tools that enable more precise guidance during heart surgery, said Volcano Corp. VP Joe Burnett, referring to the increased number of imaging-related presentations at the recent American College of Cardiology (ACC) Annual Meeting 2009.) Speaking at the conference, former ACC President Pamela Douglas, M.D. said that imaging is growing faster than all other procedures, services and diagnostic tests
      Read Full Article
      Mentions: Axsun Technologies Volcano Corporation Joe Burnett

    18. Imaging technologies discussed, demonstrated at American College of Cardiology meeting

      Explore BioOptics World Cardiology
      MARCH 30, 2009--"Word is getting out that more precise guidance during PCI [percutaneous coronary intervention] is important, and the sheer number of talks focused on higher resolution tools highlights the increased demand for access to these technologies," said Volcano Corp. (San Diego, CA) VP Joe Burnett, referring to technologies such as optical coherence tomography (OCT) being discussed at this week's American College of Cardiology (ACC) Annual Meeting.
      Read Full Article
      Mentions: Volcano Corporation Joe Burnett Barbara G. Goode

    19. Researchers publish super-resolution OCT retina scans to encourage development of AMD-diagnosis software

      Explore BioOptics World Ophthalmology
      MARCH 20, 2009--An optical coherence tomography (OCT) system with twice the resolution of commercial instruments is the cornerstone of a project designed to shed light on age-related macular degeneration (AMD)--a leading cause of vision loss. The project produced detailed 3D images of the eyes of more than 2000 people. It leverages an OSA-led initiative to facilitate data sharing, and hopes to pave the way for new diagnostic software that might enable treatments to halt vision loss.
      Read Full Article
      Mentions: University of Pittsburgh Massachusetts Institute of Technology National Institutes of Health

    20. Low-cost camera made to prevent diabetic vision loss claims implications for microscopy, OCT

      Explore BioOptics World Ophthalmology
      Low-cost camera made to prevent diabetic vision loss claims implications for microscopy, OCT
      MARCH 18, 2009--Researchers at Indiana University (Bloomington, IN) are developing a laser scanning digital camera that runs about one-fourth the cost of its counterparts and is designed for ease of use by both clinicians and patients. They say it will broaden access to early screening for diabetic retinopathy and has implications for all biomedical imaging devices, including confocal and two-photon microscopes, and optical coherence tomography (OCT) systems.
      Read Full Article
      Mentions: National Institutes of Health Purdue University Indiana University

    21. UK-based OCT and nano-imaging firms attract investment for growth

      Explore BioOptics World Funding , Other Business News
      MARCH 9, 2009--Two British companies--NanoSight Ltd. (Amesbury, UK ) and Michelson Diagnostics (Kent, UK)--say that despite the economic downturn, they have raised investment money that will fuel growth for the coming year. Michelson is a developer of optical coherence tomography (OCT) devices, and NanoSight produces a family of instruments for the visualizing and sizing nanoparticles.
      Read Full Article
      Mentions: Michelson Diagnostics Jon Holmes Michelson Diagnostics EX1301

    22. America wakes up to 3-D human coronary artery imaging

      Explore BioOptics World Cardiology
      Dr. Tim Johnson, Medical Editor for ABC’s Good Morning America show, said he is “amazed” by the “unbelievable imagery” enabled by optical frequency-domain imaging (OFDI), an advance over optical coherence tomography (OCT) that is giving researchers their first-ever detailed look at the interior of human coronary arteries. Johnson featured the technique recently, following its presentation in the journal JACC: Cardiovascular Imaging. “We expect to see commercial devices available in a one- to two
      Read Full Article
      Mentions: Guillermo J. Tearney Brett E. Bouma Massachusetts General Hospital

    23. OCT advances promise endoscopic, image-guided therapies

      Explore BioOptics World Gastroenterology , Oncology
      At Massachusetts General Hospital's Wellman Center for Photomedicine and Harvard University, scientists have been working to apply endoscopic optical-coherence tomography (OCT) technology to identify cancer in the gastrointestinal (GI) tract. They have developed a tool that combines optical frequency-domain imaging (OFDI)--a second-generation OCT--with controllable laser thermal therapy in a separate optical channel.
      Read Full Article
      Mentions: Guillermo J. Tearney Brett E. Bouma Massachusetts General Hospital

    24. Michelson Diagnostics issues preliminary specs for clinical handheld OCT probe

      Explore BioOptics World Other Business News
      Michelson Diagnostics issues preliminary specs for clinical handheld OCT probe
      JANUARY 26, 2009--Michelson Diagnostics (London, UK) has issued a preliminary specification for its clinical optical coherence tomography (OCT) probe and processing system, which the company demonstrated this past weekend at the SPIE's BiOS exhibition. The system, named Vivosight, will be available with two probe versions--one with X-Y scanning to enable 3D mapping of flat tissue such as skin, and the other with a rigid endoscope for internal applications.
      Read Full Article
      Mentions: Michelson Diagnostics Jon Holmes Michelson Diagnostics Vivosight
    1-24 of 58 1 2 3 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Doppler, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks